ClinS-I

(n = 33)

n (%)a

ClinS-C

(n = 32)

n (%)

DailyS-I

(n = 40)

n (%)

DailyS-C (n = 34)

n (%)

Total

(ntotal = 139)

n (%)

Missing data n (%)

Age (years) (range: 18 - 84)

Male Impairment in daily living due to arm, shoulder, or hand Impaired vision (using glasses or contact lenses)

56 (34 - 60)

17 (51.5)

3 (9.1)

3 (9.1)

56 (42 - 66)

13 (40.6)

8 (25.0)

3 (9.4)

51 (36 - 65)

23 (57.5)

10 (25.0)

6 (15.0)

54 (43 - 67)

16 (47.1)

5 (14.7)

5 (14.7)

54 (40 - 65)

69 (49.6)

26 (18.7)

17 (12.2)

0 (0.0)

0 (0.0)

2 (1.4)

6 (4.3)

Medication:

§     Fragmin® (dalteparin)

§     Clexane® (enoxaparin)

§     Fraxiparine® (nadroparin)

§     Fraxiforte® (nadroparin)

§     Sandoparin® (certoparin)

§     Arixtra® (fondaparinux)

Application once daily:

§     Not specified on prescription Reason for LMWH treatment (multiple answers possible):

§     Injury/orthopedic surgery

§     Thrombosis, embolism

§     Perioperative management/bridging

§     Atrial fibrillation, myocardial infarction

§     Other

33 (100.0)

33 (100.0)

0 (0.0)

31 (93.9)

2 (6.1)

0 (0.0)

0 (0.0)

0 (0.0)

32 (100.0)

 

 

30 (93.8)

2 (6.2)

32 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

22 (55.0)

11 (27.5)

2 (5.0)

1 (2.5)

2 (2.5)

2 (5.0)

33 (82.5)

7 (17.5)

31 (77.5)

3 (7.5)

4 (10.0) 0 (0.0)

3 (7.5)

14 (41.2)

5 (14.7)

12 (35.3)

2 (5.9)

1 (2.9)

0 (0.0)

27 (79.4)

4 (11.8)

20 (58.8)

3 (8.8)

2 (5.9)

3 (8.8)

4 (11.8)

101 (72.7)

16 (11.5)

14 (10.1)

3 (2.2)

3 (2.2)

2 (1.4)

123 (88.5)

13 (9.4)

114 (82.0)

8 (5.8)

6 (4.3)

3 (2.2)

7 (5.0)

0 (0.0)

2 (1.4)

2 (1.4)

Previous outpatient s.c. injection therapies History of first self-injection in the presence of a medical professional

Injection site (multiple answers possible):

§ Thigh

§ Abdomen Adverse drug reactions (multiple answers possible):

§ Hematoma at injection site

§ Mild injection site irritation/burning

§ Hematoma in general

§ Site pain

§ Induration

§ Exanthema

§ Bleeding tendency; n = 1 met criteria for reporting an

adverse event to regulatory authority (melena)

§ Epistaxis

§ Other Unscheduled visit with physician/hospital Skipping injections:

§ 1 time

§ >3 times Reason for skipping injections (multiple answers possible):

§ Forgotten

§ Not being at home

§ Early discontinuation

§ Needle phobia

§ Other

19 (57.6)

20 (60.6)

27 (81.8)

13 (39.4)

33 (100.0)

31 (93.9)

16 (48.5)

2 (6.1)

3 (9.1)

5 (15.2)

1 (3.0)

1 (3.0)

0 (0.0)

2 (6.1)

6 (18.2)

4 (12.1)

2/4 (50.0)

0/4 (0.0)

2/4 (50.0)

1/4 (25.0)

1/4 (25.0)

0/4 (0.0)

2/4 (50.0)

23 (71.9)

18 (56.3)

24 (75.0)

15 (46.9)

29 (90.6)

26 (81.3)

17 (53.1)

2 (6.3)

0 (0.0)

0 (0.0)

2 (6.3)

0 (0.0)

1 (3.1)

2 (6.3)

3 (9.4)

6 (18.8)

4/6 (66.7)

1/6 (16.7)

5/6 (83.3)

2/6 (33.3)

0/6 (0.0)

0/6 (0.0)

0/6 (0.0)

19 (47.5)

23 (57.5)

26 (65.0)

18 (45.0)

37 (92.5)

35 (87.5)

22 (55.0)

5 (12.5)

4 (10.0)

3 (7.5)

0 (0.0)

1 (2.5)

1 (2.5)

9 (22.5)

5 (12.5)

7 (17.5)

6/7 (85.7)

1/7 (14.3)

5/7 (71.4)

1/7 (14.3)

1/7 (14.3)

1/7 (14.3)

2/7 (28.6)

15 (44.1)

20 (58.8)

20 (58.8)

16 (47.1)

17 (50.0)*

15 (44.1)

5 (14.7)

3 (8.8)

3 (8.8)

0 (0.0)

0 (0.0)

1 (2.9)

0 (0.0)

0 (0.0)

0 (0.0)

1 (2.9)

1/1 (100.0)

0/1 (0.0)

0/1 (0.0)

0/1 (0.0)

0/1 (0.0)

0/1 (0.0)

1/1 (100.0)

76 (54.7)

81 (58.3)

97 (69.8)

62 (44.6)

116 (83.5)

107 (77.0)

60 (43.2)

12 (8.6)

10 (7.2)

8 (5.8)

3 (2.2)

3 (2.2)

2 (1.4)

13 (9.4)

14 (10.1)

18 (12.9)

13/18 (72.2)

2/18 (11.1)

12/18 (66.7)

4/18 (22.2)

2/18 (11.1)

1/18 (5.6)

5/18 (27.8)

2 (1.4)

3 (2.2)

2 (1.4)

2 (1.4)

1 (0.7)

9 (6.5)

0/18 (0.0)

0/18 (0.0)